Ticker Details
ADiTx Therapeutics, Inc.
IPO Date:	June 30, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$479.37K
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.21 | 6.10%
Avg Daily Range (30 D):	$0.10 | 7.67%
Avg Daily Range (90 D):	$0.10 | 7.28%

Institutional Daily Volume
Avg Daily Volume:	.08M
Avg Daily Volume (30 D):	.6M
Avg Daily Volume (90 D):	.88M

Trade Size
Avg Trade Size (Sh.):	8
Avg Trade Size (Sh.) (30 D):	184
Avg Trade Size (Sh.) (90 D):	83

Institutional Trades
Total Institutional Trades:	23
Avg Institutional Trade:	$.7M
Avg Institutional Trade (30 D):	$.51M
Avg Institutional Trade (90 D):	$.51M
Avg Institutional Trade Volume:	M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$.99M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	K

News

Dec 17, 2025 @ 1:26 PM Stock Market Today: S&P 500, Dow Futures Gain As J... Source: Rishabh Mishra

Nov 13, 2025 @ 9:05 PM Evofem Reports Financial Results for Third Quarter... Source: Prnewswire

Oct 20, 2025 @ 8:19 PM Evofem Announces Voting Results from Special Meeti... Source: Prnewswire

Sep 11, 2025 @ 1:18 PM Evofem's "Say Vagina" Campaign Generates More than... Source: Prnewswire

Sep 9, 2025 @ 1:28 PM Evofem Anticipates Approval of Merger with Aditxt ... Source: Prnewswire

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1153.83	$451.34	$-1153.83
Diluted EPS	$-1153.83	$451.34	$-1153.83
Revenue	$M	$M	$M
Gross Profit	$M	$M	$M
Net Income / Loss	$-42.79M	$-5.23M	$-42.79M
Operating Income / Loss	$-19.57M	$-4.67M	$-19.57M
Cost of Revenue	$M	$M	$M
Net Cash Flow	$2.37M	$3.04M	$2.37M
PE Ratio

Splits
Mar 09, 2026	1:8
Nov 03, 2025	1:113
Mar 17, 2025	1:250
Oct 02, 2024	1:40
Aug 18, 2023	1:40
Sep 14, 2022	1:50